Company profile: myPOLS Biotec
1.1 - Company Overview
Company description
- Provider of best-in-class DNA polymerases, master mixes, DNA polymerase-based assays, and reagents in liquid and lyophilized formats for IVD and research use, based in Konstanz, Germany.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to myPOLS Biotec
Harbour Antibodies
HQ: United States
Website
- Description: Provider of transgenic mouse technology for engineering mice to produce high affinity human antibodies. Established in 2006, leveraging technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC (Rotterdam, the Netherlands). The company has developed two types of human immunoglobulin gene transgenic mice.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Harbour Antibodies company profile →
Centrillion Technologies
HQ: United States
Website
- Description: Provider of genomics and DNA analysis technologies for personalized medicine, life sciences research, and bioinformatics, offering whole genome genotyping assays; spatial transcriptomics at micron-scale resolution; high-throughput virus detection using ATOM chips; SARS-CoV-2 whole genome sequencing on QuadCore chips; VirusHunter assays for SARS-CoV-2 and Influenza A/B; and customizable ATOM chips for detecting pathogens, antibiotic resistance genes, and controls.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Centrillion Technologies company profile →
Enza Biotech
HQ: Sweden
Website
- Description: Provider of research and development of renewable surfactants using carbohydrate-based chemistry, operating at the intersection of science and business to support the transition from a fossil-dependent to a biobased society; founded in 2012 and based at Chemical Center in Lund, Southern Sweden.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enza Biotech company profile →
Biocoat
HQ: United States
Website
- Description: Provider of custom-engineered biomaterial coatings for medical devices, specializing in lubricious hydrophilic coatings that deliver lubricity, durability, and low particulate counts. Services include contract coating, custom polymer synthesis, and reagent fulfillment, with specialized hydrophilic solutions for neurovascular and cardiovascular devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biocoat company profile →
MILabs
HQ: The Netherlands
Website
- Description: Provider of high-end molecular imaging solutions for biomedical research, including systems for quantitative 3D functional imaging of SPECT (U-SPECT) and PET (U-PET) tracers, an integrated PET/SPECT platform for simultaneous high-resolution imaging (VECTor), and automated quantitative 3D autoradiography of tissue samples with multiple isotopes (EXIRAD-3D).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MILabs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for myPOLS Biotec
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to myPOLS Biotec
2.2 - Growth funds investing in similar companies to myPOLS Biotec
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for myPOLS Biotec
4.2 - Public trading comparable groups for myPOLS Biotec
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →